tiprankstipranks
Lyell Immunopharma (LYEL)
NASDAQ:LYEL
US Market
LYEL
Lyell Immunopharma
RESEARCH TOOLSreports
Want to see LYEL full AI Analyst Report?

Lyell Immunopharma (LYEL) Income Statement

159 Followers

Lyell Immunopharma Income Statement

Last quarter (Q4 2025), Lyell Immunopharma's total revenue was $6.00K, a decrease of -45.45% from the same quarter last year. In Q4, Lyell Immunopharma's net income was $-140.72M. See Lyell Immunopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 36.00K$ 61.00K$ 130.00K$ 84.68M$ 10.65M
Gross Profit
$ -11.50M$ 61.00K$ 130.00K$ 84.68M$ 10.65M
Operating Expenses
$ 192.27M$ 358.82M$ 247.14M$ 271.74M$ 225.43M
Depreciation and Amortization
$ 11.54M$ 19.63M$ 20.25M$ 18.02M$ 13.62M
EBITDA
$ -192.24M$ -200.64M$ -226.76M$ -169.04M$ -201.15M
Operating Income
$ -203.77M$ -358.75M$ -247.01M$ -187.06M$ -214.78M
Other Income/Expenses
$ -70.67M$ 15.76M$ 12.38M$ 3.94M$ -35.44M
Pretax Income
$ -274.45M$ -342.99M$ -234.63M$ -183.12M$ -250.22M
Net Income
$ -274.45M$ -342.99M$ -234.63M$ -183.12M$ -250.22M
Per Share Metrics
Basic EPS
$ -16.06$ -1.31$ -0.93$ -0.74$ -1.03
Diluted EPS
$ -16.06$ -1.31$ -0.93$ -0.74$ -1.03
Weighted Average Shares Outstanding
 17.09M 13.07M 12.55M 12.35M 12.14M
Weighted Average Shares Outstanding (Diluted)
 17.09M 13.07M 12.55M 12.35M 12.14M
Currency in USD

Lyell Immunopharma Earnings and Revenue History